International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
《International Immunopharmacology》期刊已被查看: 次
此期刊被最新的JCR期刊SCIE收录
期刊官网:https://www.journals.elsevier.com/international-immunopharmacology |
---|
期刊投稿网址:https://www.editorialmanager.com/INTIMP |
PubMed Central (PMC)链接 :http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D |
通讯地:ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE |
中国科学院《国际期刊预警名单(试行)》名单 |
2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 此期刊被最新的JCR期刊SCIE收录 |
版面费 | 审稿速度 | 收录数据库 | 是否oa | 研究方向 |
---|---|---|---|---|
平均2.7个月<br>来源Elsevier官网:平均7.5周 | SCIE,Scopus | No | 医学-免疫学 |
大类学科 | 分区 | 小类学科 | Top期刊 | 综述期刊 |
---|---|---|---|---|
医学 | 2区 | IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学 |
是 |
版本 | 按学科 | 分区 | 影响因子 |
---|---|---|---|
2023-2024年最新版 | IMMUNOLOGY PHARMACOLOGY & PHARMACY |
Q1 | 4.8 |
Journal of Inclusive Postsecondary EducationJCR:0区,分类:影响因子0收录DOAJ
详情StichprobenJCR:0区,分类:影响因子0收录DOAJ
详情EManagementJCR:0区,分类:影响因子0收录DOAJ
详情Metathesis Journal of English Language Literature and TeachingJCR:0区,分类:影响因子0收录DOAJ
详情Clinical Psychology in EuropeJCR:0区,分类:影响因子0收录Scopus,DOAJ
详情Ius InkarriJCR:0区,分类:影响因子0收录DOAJ
详情Medichna nauka UkrayiniJCR:0区,分类:影响因子0收录DOAJ
详情Economics LawJCR:0区,分类:影响因子0收录DOAJ
详情